Clinical Trials Browser

NIH × Pancreatic Neoplasms × Dasatinib × Clear all

NCT01660971 2026-03-18

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT00474812 2015-05-05

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

51 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms